Naproxcinod Completed Phase 3 Trials for Osteoarthritis, Hip / Osteoarthritis (OA) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00541489Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
NCT00542555Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee